William Demers

Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The private company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million.

Contract Pharmaceuticals Ltd. is a contract development and manufacturing organization (CDMO) specializing in non-sterile liquid and semi-solid pharmaceutical products. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Canadian company has over 25 years of experience in the industry and has built its expertise in liquids and semi-solids. The company's product development team consists of 45 people, including more than 30 scientists, with decades of formulation development and analytical experience. The company was founded in 1991, and Jan Sahai has been the CEO of the company since 2005.

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.